Expert Discusses Frontline Standards Dosing and Novel Agents in Pancreatic Cancer

Expert Discusses Frontline Standards, Dosing, and Novel Agents in Pancreatic Cancer

Benjamin Weinberg, MD, discusses frontline standards of care in metastatic pancreatic cancer and highlights emerging agents targeting the stroma.

More From BioPortfolio on "Expert Discusses Frontline Standards, Dosing, and Novel Agents in Pancreatic Cancer"